Jessica Tassan
Stock Analyst at Piper Sandler
(1.02)
# 2,713
Out of 4,479 analysts
49
Total ratings
27.27%
Success rate
-12.57%
Average return
Main Sectors:
Top Industries:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI Cigna | Initiates: Overweight | $400 | $326.27 | +22.60% | 1 | Jun 26, 2024 | |
| MPLN MultiPlan | Initiates: Neutral | $2 | $0.32 | +534.92% | 1 | Jun 26, 2024 | |
| HUM Humana | Initiates: Overweight | $392 | $373.49 | +4.96% | 1 | Jun 26, 2024 | |
| OSCR Oscar Health | Initiates: Overweight | $25 | $15.87 | +57.53% | 1 | Jun 26, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $15 → $14 | $6.07 | +130.64% | 7 | Jun 6, 2024 | |
| PINC Premier | Maintains: Neutral | $24 → $22 | $18.58 | +18.41% | 3 | May 8, 2024 | |
| ALHC Alignment Healthcare | Upgrades: Overweight | $6 → $8 | $7.97 | +0.38% | 3 | May 8, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $566 → $571 | $494.65 | +15.44% | 4 | Apr 17, 2024 | |
| CVS CVS Health | Maintains: Overweight | $93 → $94 | $58.15 | +61.65% | 3 | Mar 15, 2024 | |
| TDOC Teladoc Health | Maintains: Overweight | $30 → $25 | $9.32 | +168.24% | 3 | Feb 21, 2024 | |
| ACCD Accolade | Maintains: Overweight | $12 → $15 | $3.54 | +323.73% | 4 | Jan 9, 2024 | |
| DOCS Doximity | Maintains: Neutral | $21 → $23 | $27.47 | -16.27% | 3 | Nov 10, 2023 | |
| CMAX CareMax | Downgrades: Neutral | $60 | $2.35 | +2,453.19% | 3 | Nov 10, 2023 | |
| PHR Phreesia | Maintains: Overweight | $43 → $40 | $20.67 | +93.52% | 3 | Sep 12, 2023 | |
| OMCL Omnicell | Downgrades: Neutral | $66 → $70 | $26.65 | +162.66% | 4 | Aug 2, 2023 | |
| AMWL American Well | Downgrades: Neutral | $5 → $3.5 | $0.25 | +1,300.00% | 2 | Feb 27, 2023 | |
| MDRX Veradigm | Downgrades: Neutral | $17 → $19 | $9.50 | +94.74% | 1 | Feb 1, 2023 | |
| EVH Evolent Health | Maintains: Overweight | $40 → $33 | $18.41 | +79.25% | 2 | Nov 4, 2022 |
Cigna
Jun 26, 2024
Initiates: Overweight
Price Target: $400
Current: $326.27
Upside: +22.60%
MultiPlan
Jun 26, 2024
Initiates: Neutral
Price Target: $2
Current: $0.32
Upside: +534.92%
Humana
Jun 26, 2024
Initiates: Overweight
Price Target: $392
Current: $373.49
Upside: +4.96%
Oscar Health
Jun 26, 2024
Initiates: Overweight
Price Target: $25
Current: $15.87
Upside: +57.53%
Health Catalyst
Jun 6, 2024
Maintains: Overweight
Price Target: $15 → $14
Current: $6.07
Upside: +130.64%
Premier
May 8, 2024
Maintains: Neutral
Price Target: $24 → $22
Current: $18.58
Upside: +18.41%
Alignment Healthcare
May 8, 2024
Upgrades: Overweight
Price Target: $6 → $8
Current: $7.97
Upside: +0.38%
UnitedHealth Group
Apr 17, 2024
Maintains: Overweight
Price Target: $566 → $571
Current: $494.65
Upside: +15.44%
CVS Health
Mar 15, 2024
Maintains: Overweight
Price Target: $93 → $94
Current: $58.15
Upside: +61.65%
Teladoc Health
Feb 21, 2024
Maintains: Overweight
Price Target: $30 → $25
Current: $9.32
Upside: +168.24%
Accolade
Jan 9, 2024
Maintains: Overweight
Price Target: $12 → $15
Current: $3.54
Upside: +323.73%
Doximity
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $27.47
Upside: -16.27%
CareMax
Nov 10, 2023
Downgrades: Neutral
Price Target: $60
Current: $2.35
Upside: +2,453.19%
Phreesia
Sep 12, 2023
Maintains: Overweight
Price Target: $43 → $40
Current: $20.67
Upside: +93.52%
Omnicell
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $26.65
Upside: +162.66%
American Well
Feb 27, 2023
Downgrades: Neutral
Price Target: $5 → $3.5
Current: $0.25
Upside: +1,300.00%
Veradigm
Feb 1, 2023
Downgrades: Neutral
Price Target: $17 → $19
Current: $9.50
Upside: +94.74%
Evolent Health
Nov 4, 2022
Maintains: Overweight
Price Target: $40 → $33
Current: $18.41
Upside: +79.25%